Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy

Crohn's disease (CD) may have some severe complications that pose an increasing health burden and negatively impact the quality of life. There are two major types - intestinal and extraintestinal complications, in which immune and non-immune mechanisms take place. We aimed to search for some as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Velikova Tsvetelina, Miladinova R., Ivanova-Todorova E., Kyurkchiev D., Spasova Z.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2018
Materias:
R
Acceso en línea:https://doaj.org/article/9d15b7e8c7fe426494c1e08b28fe141a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9d15b7e8c7fe426494c1e08b28fe141a
record_format dspace
spelling oai:doaj.org-article:9d15b7e8c7fe426494c1e08b28fe141a2021-12-02T19:11:32ZExtraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy0324-175010.2478/amb-2018-0003https://doaj.org/article/9d15b7e8c7fe426494c1e08b28fe141a2018-03-01T00:00:00Zhttps://doi.org/10.2478/amb-2018-0003https://doaj.org/toc/0324-1750Crohn's disease (CD) may have some severe complications that pose an increasing health burden and negatively impact the quality of life. There are two major types - intestinal and extraintestinal complications, in which immune and non-immune mechanisms take place. We aimed to search for some associations between specific extraintestinal manifestation and intestinal complications in CD patients with some clinicallaboratory findings, immunological markers, and the therapy administered. We examined retrospectively medical files of 26 patients with CD at mean age 42 ± 13 years, including the laboratory results. The immunological markers fecal calprotectin (FC) and fecal lactoferrin (FL) were assessed in frozen fecal samples of the chosen patients. Seventy-three percent of the investigated CD patients had some extraintestinal manifestation and/or intestinal complications, at least 13/26 had intestinal complications. All three patients with extraintestinal signs were positive for FC and 2/3 were positive for FL. We observed a higher serum level of CRP (24.49 mg/l vs. 3.13 mg/l, p = 0.010), slightly lowered serum level of hemoglobin (120 g/l vs. 145 g/l, p = 0.044) and about 2-fold lower iron level (7.23 μmol/l vs. 14.0 μmol/l, p = 0.019) in patients with intestinal complications compared to patients without complications, respectively. Four out of thirteen patients with intestinal complications were without immunosuppressive therapy at the time of our study, and nine out of thirteen - on immunosuppressive drugs. Routine laboratory and immunology testing could be beneficial for gastroenterologists in identifying patients at high risk for the development of complications and in the decision making for more aggressive therapy early after diagnosis.Velikova TsvetelinaMiladinova R.Ivanova-Todorova E.Kyurkchiev D.Spasova Z.Sciendoarticlecrohn’s diseasecomplicationsfecal calprotectinfecal lactoferrinimmunosuppressive drugsMedicineRENActa Medica Bulgarica, Vol 45, Iss 1, Pp 16-21 (2018)
institution DOAJ
collection DOAJ
language EN
topic crohn’s disease
complications
fecal calprotectin
fecal lactoferrin
immunosuppressive drugs
Medicine
R
spellingShingle crohn’s disease
complications
fecal calprotectin
fecal lactoferrin
immunosuppressive drugs
Medicine
R
Velikova Tsvetelina
Miladinova R.
Ivanova-Todorova E.
Kyurkchiev D.
Spasova Z.
Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
description Crohn's disease (CD) may have some severe complications that pose an increasing health burden and negatively impact the quality of life. There are two major types - intestinal and extraintestinal complications, in which immune and non-immune mechanisms take place. We aimed to search for some associations between specific extraintestinal manifestation and intestinal complications in CD patients with some clinicallaboratory findings, immunological markers, and the therapy administered. We examined retrospectively medical files of 26 patients with CD at mean age 42 ± 13 years, including the laboratory results. The immunological markers fecal calprotectin (FC) and fecal lactoferrin (FL) were assessed in frozen fecal samples of the chosen patients. Seventy-three percent of the investigated CD patients had some extraintestinal manifestation and/or intestinal complications, at least 13/26 had intestinal complications. All three patients with extraintestinal signs were positive for FC and 2/3 were positive for FL. We observed a higher serum level of CRP (24.49 mg/l vs. 3.13 mg/l, p = 0.010), slightly lowered serum level of hemoglobin (120 g/l vs. 145 g/l, p = 0.044) and about 2-fold lower iron level (7.23 μmol/l vs. 14.0 μmol/l, p = 0.019) in patients with intestinal complications compared to patients without complications, respectively. Four out of thirteen patients with intestinal complications were without immunosuppressive therapy at the time of our study, and nine out of thirteen - on immunosuppressive drugs. Routine laboratory and immunology testing could be beneficial for gastroenterologists in identifying patients at high risk for the development of complications and in the decision making for more aggressive therapy early after diagnosis.
format article
author Velikova Tsvetelina
Miladinova R.
Ivanova-Todorova E.
Kyurkchiev D.
Spasova Z.
author_facet Velikova Tsvetelina
Miladinova R.
Ivanova-Todorova E.
Kyurkchiev D.
Spasova Z.
author_sort Velikova Tsvetelina
title Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
title_short Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
title_full Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
title_fullStr Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
title_full_unstemmed Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
title_sort extraintestinal manifestations and intestinal complications in patients with crohn's disease: associations with some clinico-laboratory findings, immunological markers and therapy
publisher Sciendo
publishDate 2018
url https://doaj.org/article/9d15b7e8c7fe426494c1e08b28fe141a
work_keys_str_mv AT velikovatsvetelina extraintestinalmanifestationsandintestinalcomplicationsinpatientswithcrohnsdiseaseassociationswithsomeclinicolaboratoryfindingsimmunologicalmarkersandtherapy
AT miladinovar extraintestinalmanifestationsandintestinalcomplicationsinpatientswithcrohnsdiseaseassociationswithsomeclinicolaboratoryfindingsimmunologicalmarkersandtherapy
AT ivanovatodorovae extraintestinalmanifestationsandintestinalcomplicationsinpatientswithcrohnsdiseaseassociationswithsomeclinicolaboratoryfindingsimmunologicalmarkersandtherapy
AT kyurkchievd extraintestinalmanifestationsandintestinalcomplicationsinpatientswithcrohnsdiseaseassociationswithsomeclinicolaboratoryfindingsimmunologicalmarkersandtherapy
AT spasovaz extraintestinalmanifestationsandintestinalcomplicationsinpatientswithcrohnsdiseaseassociationswithsomeclinicolaboratoryfindingsimmunologicalmarkersandtherapy
_version_ 1718377105033527296